Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-012108

President and COO sold 8,000 shares at $233.29 ($1,866,320)

  • President and COO acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Douglas Robert Andrew President and COO 2022-04-18 Option exercise +8,000 $58.24 $465,920 25,175 D: show line 1 in the form
Douglas Robert Andrew President and COO 2022-04-18 Sale −8,000 $233.29 $1,866,320 17,175 D: show line 2 in the form
Open-market sales · 8,000 sh · avg $233.29 · $1,866,320

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Douglas Robert Andrew President and COO 2022-04-18 Option exercise · ResMed Common Stock Options −8,000 54,098 D: show line 3 in the form
Loading xslF345X03/form4.xml…